Please ensure Javascript is enabled for purposes of website accessibility

National COVID-19 Clinical Evidence Taskforce Guideline

Home » Resources » Guidelines » National COVID-19 Clinical Evidence Taskforce Guideline

The National COVID-19 Clinical Evidence Taskforce (NC19CET) brings together the peak health professional bodies across Australia, including THANZ, whose members are providing clinical care to people with COVID-19.

The NC19CET is undertaking continuous evidence surveillance to identify and rapidly synthesise emerging research in order to provide national, evidence-based guidelines for the clinical care of people with COVID-19. The guidelines address questions that are specific to managing COVID-19 and cover the full disease course across mild, moderate, severe and critical illness.

These are ‘living’ guidelines, updated with new research in near real-time in order to give reliable, up-to-the minute advice to clinicians providing frontline care in this unprecedented global health crisis.

The most recent Anticoagulants guideline is available here

The full NC19CET guideline is available here

More information about the NC19CET is available on their web site

Our Sponsors

2024 Corporate Sponsor

THANZ receives financial assistance from the following corporate supporter
© 2024
 Thrombosis & Haemostasis Society of Australia and New Zealand